NCT01552356 2026-03-18Pazopanib Hydrochloride in Treating Patients With Advanced or Refractory Solid TumorsNational Cancer Institute (NCI)Phase 1 Active not recruiting54 enrolled
NCT07444619 2026-03-03A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue SarcomasM.D. Anderson Cancer CenterPhase 1 Not yet recruiting18 enrolled